History of Methadone and Buprenorphine Opioid Agonist Therapy Among People Who Died of an Accidental Opioid-Involved Overdose: Rhode Island, January 1, 2018–June 30, 2020

To guide intervention efforts, we identified the proportion of individuals previously engaged in opioid agonist therapy among people who died of an accidental opioid-involved overdose. Most individuals (60.9%) had never received any prior buprenorphine or methadone treatment. Individuals who died of an overdose in 2020 had a similar demographic profile and treatment history compared with prior years. To prevent additional accidental opioid-involved overdose deaths, efforts should be directed toward linking individuals to care. (Am J Public Health. Published online ahead of print August 19, 2021: e1–e4. https://doi.org/10.2105/AJPH.2021.306395 )

Download Full-text

Risk of discharge against medical advice among hospital inpatients with a history of opioid agonist therapy in New South Wales, Australia: A cohort study and nested crossover-cohort analysis

Drug and Alcohol Dependence ◽

10.1016/j.drugalcdep.2020.108343 ◽

2020 ◽

Vol 217 ◽

pp. 108343 ◽

Cited By ~ 1

Author(s):

Dan Lewer ◽

Nicola R Jones ◽

Matthew Hickman ◽

Sarah Larney ◽

Nadine Ezard ◽

...

Keyword(s):

New South ◽

Cohort Analysis ◽

Medical Advice ◽

Agonist Therapy ◽

Opioid Agonist ◽

Opioid Agonist Therapy ◽

South Wales ◽

History Of ◽

Discharge Against Medical Advice ◽

Hospital Inpatients

Download Full-text

Opioid agonist therapy trajectories among street entrenched youth in the context of a public health crisis

SSM - Population Health ◽

10.1016/j.ssmph.2020.100609 ◽

2020 ◽

Vol 11 ◽

pp. 100609 ◽

Cited By ~ 1

Author(s):

Valerie Giang ◽

Madison Thulien ◽

Ryan McNeil ◽

Kali Sedgemore ◽

Haleigh Anderson ◽

...

Keyword(s):

Public Health ◽

Agonist Therapy ◽

Opioid Agonist ◽

Health Crisis ◽

Opioid Agonist Therapy ◽

Public Health Crisis

Download Full-text

Opioid agonist therapy uptake among people who inject drugs: The findings of two consecutive bio-behavioral surveillance surveys in Iran

10.21203/rs.3.rs-24098/v2 ◽

2020 ◽

Author(s):

Mehran Nakhaeizadeh ◽

Zahra Abdolahiniya ◽

Hamid Sharifi ◽

Ali Mirzazadeh ◽

Mostafa Shokoohi ◽

...

Keyword(s):

Health Outcomes ◽

Harm Reduction ◽

People Who Inject Drugs ◽

World Health ◽

Agonist Therapy ◽

Opioid Agonist ◽

Behavioral Surveillance ◽

Opioid Agonist Therapy ◽

Opioid Drugs ◽

History Of

Abstract Background Opioid agonist therapy (OAT) uptake has been associated with multiple positive health outcomes among people who inject drugs (PWID). This study evaluated the pattern of OAT uptake among PWID in two consecutive national bio-behavioral surveillance surveys (2010 and 2014) in Iran.Methods Data were obtained from two national bio-behavioral surveillance surveys (N2010 = 1,783 and N2014 = 2,166) implemented using convenience sampling at the harm reduction facilities and street venues in 10 geographically diverse urban centers across Iran. Multivariable logistic regression models were built to determine the correlates of OAT uptake for the 2014 survey and adjusted odds ratios (AORs) and 95% confidence intervals (CI) were reported.Results The prevalence of OAT uptake decreased from 49.2% in 2010 to 45.8% in 2014 (P-value = 0.033). OAT uptake varied across the studied cities ranging from 0.0%-69.3% in the 2010 survey and 3.2%-75.5% in the 2014 survey. Ever being married (AOR = 1.40; 95% CI: 1.12, 1.75), having a history of incarceration (AOR = 1.56; 95% CI: 1.16, 2.09), and human immunodeficiency virus (HIV) sero-positivity (AOR = 1.63; 95% CI: 1.08, 2.5) were associated with OAT uptake. Conversely, PWID who reported using only non-opioid drugs (AOR = 0.43; 95% CI: 0.26, 0.71) and those who reported concurrent use of opioid and non-opioid drugs (AOR = 0.66; 95% CI: 0. 0.51, 0.86) were less likely to uptake OAT. Conclusions Although OAT uptake among PWID in Iran is above the 40% threshold defined by the World Health Organization, there remains significant disparities across urban settings in Iran. Importantly, the OAT services appear to be serving high-risk PWID including those living with HIV and those with a history of incarceration. Evaluating service integration including mental health, HIV and hepatitis C virus care, and other harm reduction services may support the optimization of health outcomes of OAT across Iran.

Download Full-text